Revitalist Addresses Opioid Epidemic Through Non-Medicative Interventions with TMS Representing a $195 Billion USD Market
Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF) is enhancing its revenue potential by introducing Transcranial Magnetic Stimulation (TMS) to address chronic pain and mental health. Given that over 50 million Americans suffer from chronic pain, this innovative, non-medicative approach aims to combat the opioid crisis, which costs society over $1.3 trillion annually. TMS services will be offered in five of its ten clinics across Kentucky and Tennessee, targeting a direct population of over 1 million individuals in need.
- Introduction of TMS services could attract a new patient demographic.
- Targeting over 1 million individuals addresses a significant market need.
- No specific financial metrics provided to gauge expected revenue impact.
- Dependence on TMS success amidst broader opioid crisis may pose risks.
Researchers have estimated more than 50 million Americans suffer with chronic pain. The opioid epidemic coupled with lack of access for safe, evidenced-based interventions continues to cause an increase in illicit drug use, overdoses, and death costing society more than
Revitalist will now offer TMS services addressing pain conditions (along with mental health conditions) utilizing their unique skillset of translational medicine to a direct population of more than 1 million individuals in need of these services.
Revitalist will offer these services at five of their ten locations including:
ABOUT
Twitter: @RevitalistCorp
Facebook: @RevitalistLifestyleandWellnessLtd.
Instagram: @RevitalistCorp
LinkedIn: @RevitalistLifestyleAndWellnessLtd
On Behalf of the Board
Chief Executive Officer
Forward Looking Statements
This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.
Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005178/en/
Email: IR@revitalist.com
Tel: (865) 585-8414
Source:
FAQ
What is Revitalist Lifestyle and Wellness Ltd. (RVLWF) introducing to address chronic pain?
How many clinics will offer TMS services from Revitalist?
What is the estimated number of Americans suffering from chronic pain?
What is the financial impact of the opioid crisis mentioned by Revitalist?